How likely is flu-related pneumonia to happen to you? What are the symptoms to look out for when they can be similar to those ...

By combining MERFISH imaging with expansion microscopy, researchers have unlocked a new way to study bacteria at the ...

The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.

Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

Addresses the significant threat of antimicrobial resistance.

A sore throat usually isn't serious enough for a trip to the doctor, and many natural remedies can help ease your symptoms, ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Some bacteria have evolved to beat modern medication - but one natural kitchen cupboard item could be the key to stop them ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...